InnAVasc Medical, Inc. — Form D
InnAVasc Medical, Inc. of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2016-11-04. The offering totals $3.3M, of which $2.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-11-04
- Form: D
- Accession: 0001671622-16-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.3M
- Amount sold: $2.1M
- Remaining: $1.1M
- Investors: 39
- Date of first sale: 2016-10-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-273820
Issuer
- Name: InnAVasc Medical, Inc.
- CIK: 0001671622
- Entity type: Corporation
- Jurisdiction: NORTH CAROLINA
- Incorporated: 2013
- Address: 110 SWIFT AVENUE, DURHAM, NC, 27705
- Phone: 919-558-1200
Officers, directors & promoters (21)
| Name | Role | Location |
|---|
| Dani Duane Bolognesi | Director | Durham, NC |
| Jeffrey Lawson | Director | San Francisco, CA |
| Shawn Gage | Executive Officer | Durham, NC |
| Jeffrey Lawson | Executive Officer | San Francisco, CA |
| Roberto Duane Manson | Executive Officer | Durham, NC |
| Greg Davis | Director | San Diego, CA |
| Kenneth Gall | Director | Atlanta, GA |
| Joseph Knight | Director | San Francisco, CA |
| Joseph Knight | Executive Officer | San Francisco, CA |
| C. Steven Duncker | Director | Durham, NC |
| Craig N Nichols | Executive Officer | Durham, NC |
| Jeffrey N Lawson | Director | Durham, NC |
| C Steven Duncker | Director | Durham, NC |
| William N Starling | Director | Durham, NC |
| Greg N Davis | Director | Durham, NC |
| Kenneth N Gall | Director | Durham, NC |
| William Starling,Jr. | Director | Durham, NC |
| Craig Nichols | Executive Officer | Durham, NC |
| Stephen Duncker | Director | Durham, NC |
| Roberto Manson | Executive Officer | RESEARCH TRIANGLE PARK, NC |
| Dani Bolognesi | Director | RESEARCH TRIANGLE PARK, NC |
Other filings by this issuer (4)
More